Paraplegia in childhood malignant disease.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000150:complications*; D008228:Lymphoma, Non-Hodgkin / Q000150:complications*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D010264:Paraplegia / Q000209:etiology* / Q000628:therapy; D011239:Prednisolone / Q000627:therapeutic use; D012186:Retroperitoneal Neoplasms / Q000150:complications; D012512:Sarcoma, Ewing / Q000150:complications*; D013120:Spinal Cord Neoplasms / Q000150:complications*; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use; D009396:Wilms Tumor / Q000150:complications*
D003609:Dactinomycin; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D011239:Prednisolone; D015122:Mercaptopurine; D008727:Methotrexate